ANGIODYNAMICS INC — Director's Dealing 2019

Aug 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2019-07-12

Reporting Person: Simpson Robert Arthur (SVP/GM, Global Vascular)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-12	Common Stock	M	15600	—	Acquired	31041	Direct
2019-07-12	Common Stock	F	5158	$21.68	Disposed	25883	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-12	Performance Right	$	M	30000	Acquired		Common Stock (30000)	Direct

Footnotes

F1: This acquisition of 15,600 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on January 31, 2017.

F2: The exempt disposition of 5,158 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on January 31, 2017.

F3: On January 31, 2017, the reporting person received a target grant of 30,000 performance share units vesting between 0% and 200%. The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019. Based on the Company's performance over this period, 15,600 shares of Common Stock were issued to the reporting person under this grant.